MARKSANS PHARMA
Back to Balance Sheet
|
MARKSANS PHARMA Last 5 Year Total Non-Current Liabilities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Total Non-Current Liabilities | ₹268 Cr | ₹273 Cr | ₹205 Cr | ₹84 Cr | ₹57 Cr |
What is the latest Total Non-Current Liabilities ratio of MARKSANS PHARMA ?
| Year | Total Non-Current Liabilities |
|---|---|
| Mar2026 | ₹268 Cr |
| Mar2025 | ₹273 Cr |
| Mar2024 | ₹205 Cr |
| Mar2023 | ₹84 Cr |
| Mar2022 | ₹57 Cr |
How is Total Non-Current Liabilities of MARKSANS PHARMA Trending?
| Years | Total Non-Current Liabilities | % Change | |
|---|---|---|---|
| Mar2026 | ₹268 Cr | -1.74 | |
| Mar2025 | ₹273 Cr | 33.00 | |
| Mar2024 | ₹205 Cr | 143.34 | |
| Mar2023 | ₹84 Cr | 47.80 | |
| Mar2022 | ₹57 Cr | - | |
Compare Total Non-Current Liabilities of peers of MARKSANS PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| MARKSANS PHARMA | ₹14,636.1 Cr | 1.4% | 25.1% | 85.3% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹469,310.0 Cr | 2% | -1.7% | 15.9% | Stock Analytics | |
| DIVIS LABORATORIES | ₹245,426.0 Cr | 6.5% | 14.8% | 48.4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹189,347.0 Cr | 1.2% | -2.5% | 37.2% | Stock Analytics | |
| CIPLA | ₹114,393.0 Cr | -0.3% | -3.9% | -11.4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹97,240.2 Cr | -2.2% | 1.5% | -8.3% | Stock Analytics | |
MARKSANS PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| MARKSANS PHARMA | 1.4% |
25.1% |
85.3% |
| SENSEX | -0.5% |
-1.3% |
-5.4% |
You may also like the below Video Courses